SCHEMBL9613474

SCHEMBL9613474

CN[C@@H](C)C(=O)N[C@H](C(=O)N1CC[C@H]2NC[C@H](Oc3ccc4ccccc4c3)[C@H]21)C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
XIAP P98170 13/20 0.43
BIRC2 Q13490 12/20 0.43
BIRC3 Q13489 7/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8515048 1.00 XIAP (0.43) XIAPBIRC2BIRC3
SCHEMBL8510612 0.89 XIAP (0.42) XIAPBIRC2BIRC3
SCHEMBL9613408 0.89 XIAP (0.42) XIAPBIRC2BIRC3
SCHEMBL9613434 0.86 XIAP (0.43) XIAPBIRC2BIRC3
SCHEMBL8514257 0.86 XIAP (0.43) XIAPBIRC2BIRC3
SCHEMBL8511123 0.84 XIAP (0.46) XIAPBIRC2BIRC3
SCHEMBL9613480 0.84 XIAP (0.46) XIAPBIRC2BIRC3
SCHEMBL8514040 0.82 BIRC2 (0.46) XIAPBIRC2BIRC3
SCHEMBL13017629 0.82 BIRC2 (0.46) XIAPBIRC2BIRC3
SCHEMBL8514034 0.82 BIRC2 (0.46) XIAPBIRC2BIRC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415486-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS CORP. (US) 2013-04-09 US disclosed
US-20120135990-A1 IAP INHIBITORS TETRALOGIC PHARMACEUTICALS CORP. (US) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135990-A1 IAP INHIBITORS XIAP, IAPP, BIRC5 XIAP 1/4885BIRC2 4/4885BIRC3 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.